dolutegravir sodium · Powder

What changed in the last 90 days

Every detected change for dolutegravir sodium, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

• abacavir sulfate, dolutegravir sodium, lamivudine· 1 maker
• dolutegravir sodium and lamivudine· 1 maker
• elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide· 1 maker
• dolutegravir sodium and rilpivirine hydrochloride· 2 makers
• elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate· 2 makers
• cabotegravir sodium· 5 makers
• raltegravir· 7 makers

Common questions

Is Dolutegravir sodium in shortage right now?

No. FDA does not currently list Dolutegravir sodium in shortage. This page is rebuilt every morning from FDA's shortage database, so a new posting appears here the day it is published.

Who makes Dolutegravir sodium?

13 companies have marketed Dolutegravir sodium in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.

What does Dolutegravir sodium cost?

The typical pharmacy pays about $77.59 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.